A phase 1 study of first-in-class agent CPI-613 in combination with FOLFIRINOX for metastatic pancreatic cancer

Saved in:

Bibliographic Details
Published in	The lancet oncology Vol. 18; no. 6; pp. 770 - 778
Main Authors	Alistar, Angela, Morris, Bonny B., Desnoyer, Rodwige, Klepin, Heidi D., Hosseinzadeh, Keyanoosh, Clark, Clancy, Cameron, Amy, Leyendecker, John, D’Agostino, Ralph, Topaloglu, Umit, Boteju, Lakmal W., Boteju, Asela R., Shorr, Rob, Zachar, Zuzana, Bingham, Paul M., Ahmed, Tamjeed, Crane, Sandrine, Shah, Riddhishkumar, Migliano, John J., Pardee, Timothy S., Miller, Lance, Hawkins, Gregory, Jin, Guangxu, Zhang, Wei, Pasche, Boris
Format	Journal Article
Language	English
Published	08.05.2017
Online Access	Get full text

Loading…

More Information
ISSN:	1470-2045 1474-5488
DOI:	10.1016/S1470-2045(17)30314-5